People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...

The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...

Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated ...

During a clinical trial, around 83% (10 out of 12) of patients who received a full dose of Zimislecel achieved complete ...

In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained ...

Women with diabetes who were overweight or had obesity lost more weight and had greater odds of diabetes remission when ...

Diabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...

A stem cell-based treatment may have cured 10 out of 12 patients with the most severe form of type 1 diabetes -- during a ...

Held June 20-23 in Chicago, Illinois, the ADA Scientific Sessions is one of the largest diabetes conferences in the world.

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...